CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 471851754
- Phone
- 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Planned sale President and CEO sold 15,000 shares at an average $16.76 ($251,349)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Planned sale President and CEO sold 45,000 shares at $15.18 ($682,992)
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes Chief Oper. & Tech. Officer gave up 8,120 shares (to pay taxes)
- 4 Planned sale Chief Medical Officer sold 17,237 shares at $17.39 ($299,789)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 8,410 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 4,534 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 11,357 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 7,893 shares (to pay taxes)
- 144 Insider Sale of Securities
- 4 Planned sale President and CEO sold 45,000 shares at $19.69 ($885,825)
Page 11 of 41 · 806 filings